Proteome Profiler Mouse Phospho-RTK Array Kit
Proteome Profiler Mouse Phospho-RTK Array Kit Summary
A membrane-based antibody array for the parallel determination of the relative levels of mouse receptor tyrosine kinase phosphorylation. Validated for analyte detection in cell lysates.
Key Benefits
- Detects phosphorylation of 39 mouse receptors simultaneously
- Requires no specialized equipment
Principle of the Assay
The Proteome Profiler Mouse Phospho-RTK Array Kit is a membrane-based sandwich immunoassay. Capture antibodies spotted in duplicate on nitrocellulose membranes bind to specific target proteins present in the sample (Step 1). Tyrosine phosphorylation of the captured proteins is detected with an HRP-conjugated pan phospho-tyrosine antibody (Step 2) and then visualized using chemiluminescent detection reagents (Step 3). The signal produced is proportional to the amount phosphorylation in the bound analyte.
Why Use an Antibody Array to Detect Receptor Phosphorylation?
Determining the phosphorylation of multiple receptors in a single sample can be expensive, time consuming and can require specialized equipment. Performing multiple immunoprecipitations and Western blots requires time, labor, and reagents. The use of a multiplex antibody array to detect multiple phosphorylations in a single sample can be cost-effective and also save time and sample.
- 4 Array Membranes
- 4-Well Multi-dish
- Array Buffers
- Lysis Buffer
- Wash Buffer
- Anti-Phospho-Tyrosine-HRP Detection Antibody
- Chemiluminescent Detection Reagents
- Transparency Overlay Template
- Detailed Protocol
For a complete list of the kit contents and necessary materials, please see the Materials Provided/Other Supplies Required sections of the product datasheet.
Stability and Storage
Store the unopened kit at 2 °C to 8 °C. Do not use past kit expiration date.
| Simultaneously detect the relative phosphorylation of these RTKs in a single sample | ||
| EGF R | PDGF R alpha | VEGF R3 |
| ErbB2 | PDGF R beta | MuSK |
| ErbB3 | SCF R | EphA1 |
| ErbB4 | Flt-3 | EphA2 |
| FGF R2 (IIIc) | M-CSF R | EphA3 |
| FGF R3 | c-Ret | EphA6 |
| FGF R4 | Tie-1 | EphA7 |
| Insulin R | Tie-2 | EphA8 |
| IGF-I R | TrkA | EphB1 |
| Axl | TrkB | EphB2 |
| DtK | TrkC | EphB4 |
| Mer | VEGF R1 | EphB6 |
| HGF R | VEGF R2 | |
| MSP R | ||
Assays for analytes represented in the Mouse Phospho-Receptor Tyrosine Kinase Array Kit
| DuoSet® ELISA Development Reagents | DuoSet® IC ELISA Development Reagents (Total) | DuoSet® IC ELISA Development Reagents (Phospho) | Quantikine® ELISA Kits | Cell-based ELISA Kits | |
| EGF R | |||||
| ErbB2 | |||||
| ErbB3 | |||||
| ErbB4 | |||||
| FGF R2 (IIIc) | |||||
| FGF R3 | |||||
| FGF R4 | |||||
| Insulin R | |||||
| IGF-I R | |||||
| Axl | DY854 | ||||
| DtK | DY759 | ||||
| Mer | DY591 | ||||
| HGF R | DY527 | ||||
| MSP R | |||||
| PDGF R alpha | |||||
| PDGF R beta | |||||
| SCF R | |||||
| Flt-3 | |||||
| M-CSF R | |||||
| c-Ret | |||||
| Tie-1 | |||||
| Tie-2 | DYC2816 | ||||
| TrkA | |||||
| TrkB | |||||
| TrkC | |||||
| VEGF R1 | DY471 | MVR100 | |||
| VEGF R2 | DY1558B | MVR200B | |||
| VEGF R3 | DY743 | ||||
| MuSK | |||||
| EphA1 | |||||
| EphA2 | |||||
| EphA3 | |||||
| EphA6 | |||||
| EphA7 | |||||
| EphA8 | |||||
| EphB1 | |||||
| EphB2 | |||||
| EphB4 | |||||
| EphB6 |
Receptor Tyrosine Kinases (RTKs) are widely expressed transmembrane proteins that act as receptors for growth factors, neurotrophic factors, and other extracellular signaling molecules. Upon ligand binding, they undergo tyrosine phosphorylation at specific residues in the cytoplasmic tail. This leads to the binding of protein substrates and/or the establishment docking sites for adaptor proteins involved in RTK-mediated signal transduction. RTKs have critical functions in several developmental processes including regulating cell survival, proliferation, and motility. When unregulated, they play prominent roles in cancer formation. R&D Systems offers several different multiplex assay formats that allow the user to assess the activity of many RTKs in a single sample. Available RTK multiplex kits include bead-based multiplex kits for the Luminex platform, membrane-based antibody arrays, and microplate-based antibody arrays.
Specifications
Product Datasheets
Data Example
Detection of Multiple Tyrosine Phosphorylated Receptors in Cell Lysates by the Mouse Phospho-RTK Array. The amount of lysate incubated with each array is indicated in the figure. Data shown are from 2 minute (Panels A, B, and C) or 5 minute (Panel D) exposure to X-ray film.A. M1 mouse myeloid leukemia cells were either untreated or treated with 500 ng/mL recombinant mouse Flt-3 Ligand (Catalog # 427-FL) for 5 minutes.B. NMuMG mouse mammary gland epithelial cells were either untreated or treated with 200 ng/mL recombinant mouse EGF (Catalog # 2028-EG) for 5 minutes.C. Hepa 1-6 mouse hepatoma cells were either untreated or treated with 1 µg/mL recombinant human insulin (Sigma, Catalog # I9278).D. HEK293 human embryonic kidney cells transfected with mouse EphA1 were either untreated or treated with 3 µg/mL mouse Ephrin-A1 (Catalog # 602-A1) and 0.3 µg/mL goat anti-human IgG Fc (Catalog # G-102-C) for 20 minutes.
Citations for Proteome Profiler Mouse Phospho-RTK Array Kit
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
26
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Combined MEK and PI3K/p110b inhibition as a novel targeted therapy for malignant mesothelioma displaying sarcomatoid features
Authors: M Marqués, R Tranchant, B Risa-Ebrí, ML Suárez-Sol, LC Fernández, E Carrillo-d, N Del Pozo, J Martínez d, C Meiller, Y Allory, Y Blum, C Pirker, B Hegedus, ST Barry, A Carnero, W Berger, D Jean, FX Real
Cancer Res., 2020;0(0):. 2020
-
PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment
Authors: J Naipauer, S Rosario, S Gupta, C Premer, O Méndez-Sol, M Schlesinge, V Ponzinibbi, V Jain, L Gay, R Renne, HL Chan, L Morey, D Salyakina, M Abba, S Williams, JM Hare, PJ Goldschmid, EA Mesri
PLoS Pathog., 2019;15(12):e1008221. 2019
-
Loss of Bardet-Biedl syndrome proteins causes synaptic aberrations in principal neurons
Authors: N Haq, C Schmidt-Hi, FJ Sialana, L Ciani, JP Heller, M Stewart, L Bentley, S Wells, RJ Rodenburg, PM Nolan, E Forsythe, MC Wu, G Lubec, P Salinas, M Häusser, PL Beales, S Christou-S
PLoS Biol., 2019;17(9):e3000414. 2019
-
Norgestrel, a Progesterone Analogue, Promotes Significant Long-Term Neuroprotection of Cone Photoreceptors in a Mouse Model of Retinal Disease
Authors: SL Roche, O Kutsyr, N Cuenca, TG Cotter
Invest. Ophthalmol. Vis. Sci., 2019;60(8):3221-3235. 2019
-
EphB2-dependent signaling promotes neuronal excitotoxicity and inflammation in the acute phase of ischemic stroke
Authors: AS Ernst, LI Böhler, AM Hagenston, A Hoffmann, S Heiland, C Sticht, M Bendszus, M Hecker, H Bading, HH Marti, T Korff, R Kunze
Acta Neuropathol Commun, 2019;7(1):15. 2019
-
Glycosylation controls cooperative PECAM-VEGFR2-?3 integrin functions at the endothelial surface for tumor angiogenesis
Authors: R Imamaki, K Ogawa, Y Kizuka, Y Komi, S Kojima, N Kotani, K Honke, T Honda, N Taniguchi, S Kitazume
Oncogene, 2018;0(0):. 2018
-
KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis
Authors: LE Cavallin, Q Ma, J Naipauer, S Gupta, M Kurian, P Locatelli, P Romanelli, M Nadji, PJ Goldschmid, EA Mesri
PLoS Pathog., 2018;14(7):e1007175. 2018
-
Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
Authors: A Yallowitz, A Ghaleb, L Garcia, EM Alexandrov, N Marchenko
Cell Death Dis, 2018;9(6):621. 2018
-
Axonal outgrowth, neuropeptides expression and receptors tyrosine kinase phosphorylation in 3D organotypic cultures of adult dorsal root ganglia
Authors: E Neto, CJ Alves, L Leitão, DM Sousa, IS Alencastre, F Conceição, M Lamghari
PLoS ONE, 2017;12(7):e0181612. 2017
-
Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling
Authors: AK Piper, SE Ross, GM Redpath, FA Lemckert, N Woolger, A Bournazos, PA Greer, RB Sutton, ST Cooper
Cell. Signal, 2017;33(0):30-40. 2017
-
Effective combinatorial immunotherapy for castration-resistant prostate cancer
Authors: X Lu, JW Horner, E Paul, X Shang, P Troncoso, P Deng, S Jiang, Q Chang, DJ Spring, P Sharma, JA Zebala, DY Maeda, YA Wang, RA DePinho
Nature, 2017;543(7647):728-732. 2017
-
Betacellulin regulates the proliferation and differentiation of retinal progenitor cells in vitro
Authors: D Zhang, B Shen, Y Zhang, N Ni, Y Wang, F Xianqun, H Sun, P Gu
J. Cell. Mol. Med., 2017;0(0):. 2017
-
OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency
Authors: M Ullrich, M Weber, AM Post, S Popp, J Grein, M Zechner, H Guerrero G, A Kreis, AG Schmitt, N Üçeyler, KP Lesch, K Schuh
Mol. Psychiatry, 2017;0(0):. 2017
-
Insulin-mediated signaling facilitates resistance to PDGFR inhibition in proneural hPDGFB-driven gliomas
Authors: DA Almiron Bo, C Ran, MC Havrda, H Liu, Y Hitoshi, Z Zhang, C Cheng, M Ung, MA Israel
Mol. Cancer Ther, 2017;0(0):. 2017
-
HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss
Authors: CH Shin, JP Robinson, JA Sonnen, AE Welker, DX Yu, MW VanBrockli, SL Holmen
Oncogene, 2017;0(0):. 2017
-
Gemcitabine-induced TIMP1 attenuates therapy response and promotes tumor growth and liver metastasis in pancreatic cancer
Authors: Z D'Costa, K Jones, A Azad, R van Stipho, SY Lim, AL Gomes, P Kinchesh, SC Smart, WG McKenna, FM Buffa, OJ Sansom, RJ Muschel, E O'Neill, E Fokas
Cancer Res., 2017;0(0):. 2017
-
Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1alpha and Notch1 in head neck squamous cell carcinoma.
Authors: Wang W, Zhao Z, Ma S, Yu G, Liu B, Zhang L, Zhang W, Kulkarni A, Sun Z, Zhao Y
PLoS ONE, 2015;10(2):e0119723. 2015
-
Decorin deficiency promotes hepatic carcinogenesis.
Authors: Horvath Z, Kovalszky I, Fullar A, Kiss K, Schaff Z, Iozzo R, Baghy K
Matrix Biol, 2014;35(0):194-205. 2014
-
Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3beta pathways in vivo.
Authors: Fullar A, Baghy K, Deak F, Peterfia B, Zsak Y, Tatrai P, Schaff Z, Dudas J, Kiss I, Kovalszky I
PLoS ONE, 2014;9(4):e93469. 2014
-
HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells.
Authors: Stone S, Rossetti R, Bolpetti A, Boccardo E, Souza P, Lepique A
J Leukoc Biol, 2014;96(4):619-31. 2014
-
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
Authors: Yang Y, Ahn Y, Chen Y, Tan X, Guo L, Gibbons D, Ungewiss C, Peng D, Liu X, Lin S, Thilaganathan N, Wistuba I, Rodriguez-Canales J, McLendon G, Creighton C, Kurie J
J Clin Invest, 2014;124(6):2696-708. 2014
-
Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals.
Authors: Miyabayashi K, Ijichi H, Mohri D, Tada M, Yamamoto K, Asaoka Y, Ikenoue T, Tateishi K, Nakai Y, Isayama H, Morishita Y, Omata M, Moses H, Koike K
Cancer Res, 2013;73(7):2221-34. 2013
-
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.
Authors: Heckl D, Schwarzer A, Haemmerle R, Steinemann D, Rudolph C, Skawran B, Knoess S, Krause J, Li Z, Schlegelberger B, Baum C, Modlich U
Mol. Ther., 2012;20(6):1187-95. 2012
-
Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease.
Authors: Haines, Christop, Harvey, Pamela A, Luczak, Elizabet, Barthel, Kristen, Konhilas, John P, Watson, Peter A, Stauffer, Brian L, Leinwand, Leslie A
Endocrinology, 2012;153(9):4470-9. 2012
-
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury.
Authors: Chen J, Chen JK, Harris RC
Kidney Int., 2012;82(1):45-52. 2012
-
Specific glycosaminoglycans modulate neural specification of mouse embryonic stem cells.
Authors: Pickford CE, Holley RJ, Rushton G, Stavridis MP, Ward CM, Merry CL
Stem Cells, 2011;29(4):629-40. 2011
FAQs
No product specific FAQs exist for this product, however you may
View all Proteome Profiler Antibody Array FAQsReviews for Proteome Profiler Mouse Phospho-RTK Array Kit
Average Rating: 4.7 (Based on 6 Reviews)
Have you used Proteome Profiler Mouse Phospho-RTK Array Kit?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
Array works and produces publishable results. Not happy with the pho-PDGFR antibody, sinse it appear to cross react with something in mouse tumor lysate
Lysates from mouse embryonic stem cells applied to membranes using instructions provided. Western blots were clean and worked great!
Worked really well on mouse tumour lysates.
Mammary tumors extracts from MMTV-Neu mice with different p53 genotypes (p53wt vs mutp53)
